PulseAI Receives U.S. FDA 510(k) Clearance of AI-Powered Arrhythmia Analysis Model for Wearables
Published study reports PulseAI model delivers up to 10x performance improvement when used with leading wearables BELFAST, Northern Ireland, Nov. 5, 2026 /PRNewswire/ --PulseAI, a medical technology company developing artificial intelligence for cardiac diagnostics, today announced U.S....
Covered in this story
Call it yourself
No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on NOV →Dalsna Finance is currently tracking 89 stories mentioning NOV, the earliest published 7 Oct 2025.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.